Phytochemical Screening And Antimicrobial Potential Of Viola Odorata Flower Hydroalcoholic Extract


  • Kiran Tiwari , Dr. Sachin Bhatt , Dr. Namrata Jain



Infectious (or communicable) diseases are not only a concern in the past, but they are also an issue now in both developing and rich countries. Pathogenic germs such as fungus, bacteria, parasites, and viruses cause it. Pathogenic microorganisms have been fought with therapeutic herbs. Herbal medications are commonly used in healthcare due to their inexpensive cost and abundance of antibacterial qualities. Herbal remedies have been utilised in most countries since ancient times, but in Asia, various medicinal plants are extensively employed as a therapy for infectious diseases in rural and backward areas. The goal of this study was to determine the antibacterial properties and phytochemical content of Viola odorata flower hydroalcoholic extract. The well-known test technique in the literature was used to determine the qualitative analysis of several phytochemical elements. The standard ofloxacin, ciprofloxacin (10-30g/ml), was used to test in vitro antimicrobial activity against Streptococcus mutans, Bacillus subtilis, Staphylococcus aureus, Salmonella bongori, Klebsiella pneumoniae, and Escherichia coli using the well diffusion assay method. The antibacterial activity was measured in millimetres by measuring the diameter of the inhibitory zone (mm). Hydroalcoholic extract of flower had antibacterial efficacy against all microbes in a concentration-dependent manner, but it was less than standard medication. The presence of these phytochemicals is thought to be responsible for the plant's antibacterial properties. Phytochemicals responsible for these effects can be identified and manipulated for pharmaceutical purposes in future investigations.



2022-12-31 — Updated on 2022-12-31

How to Cite

Kiran Tiwari , Dr. Sachin Bhatt , Dr. Namrata Jain. (2022). Phytochemical Screening And Antimicrobial Potential Of Viola Odorata Flower Hydroalcoholic Extract. Journal of Pharmaceutical Negative Results, 2434–2436.